Parkman Healthcare Partners’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,136,413
| Closed | -$1.24M | – | 99 |
|
|
2023
Q3 | $1.24M | Sell |
1,136,413
-194,203
| -15% | -$212K | 0.23% | 89 |
|
|
2023
Q2 | $3.05M | Buy |
1,330,616
+655,288
| +97% | +$1.5M | 0.53% | 57 |
|
|
2023
Q1 | $1.64M | Buy |
675,328
+254,126
| +60% | +$618K | 0.36% | 65 |
|
|
2022
Q4 | $804K | Buy |
421,202
+117,588
| +39% | +$225K | 0.21% | 74 |
|
|
2022
Q3 | $729K | Buy |
303,614
+53,614
| +21% | +$129K | 0.21% | 79 |
|
|
2022
Q2 | $465K | Buy |
+250,000
| New | +$465K | 0.17% | 70 |
|